Related Experiment Video
Updated: Aug 11, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Lower Limb Serratia marcescens Necrotizing Fasciitis Complicated by Nosocomial COVID-19
Raiyyan Aftab1, Jing Qin Tay2, Philip Sauvé3
1Plastic Surgery, Queen Alexandra Hospital, Portsmouth, GBR.
Abstract:
Serratia marcescens represents an unusual yet potentially deadly cause of lower limb necrotizing fasciitis (NF). Compounding the already high mortality of NF, S. marcescens infections are usually associated with worse outcomes (i.e., amputation). Here we present the case of a 56-year-old immunocompromised man due to lupus nephritis who developed lower limb NF secondary to S. marcescens followed by nosocomial coronavirus disease 2019 (COVID-19) pneumonitis. Successful limb salvage was achieved through a multidisciplinary team approach from various specialties including plastic surgery, orthopedic surgery, anesthesiology, intensive care, respiratory medicine, and nephrology. At 11 months' follow-up, the patient was largely independent with activities of daily living and was able to ambulate. Unfortunately, he suffered a myocardial infarction at 19 months post-operatively and passed away. A review of the literature revealed only a handful of cases of lower limb NF due to S. marcescens and none with subsequent COVID-19. Therefore, this is the first report of such a case which should help with the clinical management of such cases going forward, especially with COVID-19 now becoming endemic in our communities and contributing to delayed presentations and increased mortality in NF.
Insights
Serratia marcescens necrotizing fasciitis (NF) of the lower limb is rare and often leads to amputation. This case highlights successful limb salvage in an immunocompromised patient with a subsequent COVID-19 infection.
Area of Science:
- Infectious Diseases
- Surgery
- Critical Care Medicine
Background:
- Necrotizing fasciitis (NF) is a severe soft tissue infection with high mortality.
- Serratia marcescens is an uncommon pathogen causing NF, often associated with poor outcomes like amputation.
- Immunocompromised status, such as lupus nephritis, increases susceptibility to severe infections.
Observation:
- A 56-year-old immunocompromised male with lupus nephritis developed lower limb NF due to Serratia marcescens.
- The patient subsequently contracted nosocomial coronavirus disease 2019 (COVID-19) pneumonitis.
- A multidisciplinary team approach was crucial for managing this complex case.
Findings:
- Successful limb salvage was achieved despite the severe infection and subsequent COVID-19.
- The patient demonstrated functional recovery, ambulating independently at 11 months post-operatively.
- Literature review revealed a paucity of Serratia marcescens lower limb NF cases, with none previously reported in conjunction with COVID-19.
Implications:
- This case represents the first reported instance of lower limb Serratia marcescens NF complicated by COVID-19.
- Findings underscore the importance of a multidisciplinary approach in managing complex infectious disease scenarios.
- The study provides valuable insights for clinical management, particularly with COVID-19's endemic status impacting NF presentations and outcomes.
Related Concept Videos
Pneumonia III: Complications and Assessment
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Peripheral Artery Disease V: Postoperative Nursing Management
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

